Edgar Lomax Company’s Eli Lilly LLY Stock Holding History

Edgar Lomax Company’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-112,285	Closed	-$9.4M	–	69
2015 Q3	$9.4M	Sell	112,285 -4,050	-3%	-$342K	0.71%	37
2015 Q2	$9.71M	Sell	116,335 -1,550	-1%	-$118K	0.65%	37
2015 Q1	$8.56M	Sell	117,885 -35,600	-23%	-$2.53M	0.56%	42
2014 Q4	$10.6M	Sell	153,485 -279,090	-65%	-$18.8M	0.66%	38
2014 Q3	$28.1M	Buy	432,575 +11,100	+3%	+$703K	1.9%	22
2014 Q2	$26.2M	Buy	421,475 +1,400	+0.3%	+$83.5K	1.85%	23
2014 Q1	$24.7M	Buy	420,075 +4,150	+1%	+$232K	1.82%	23
2013 Q4	$21.2M	Sell	415,925 -225,300	-35%	-$11.3M	1.6%	27
2013 Q3	$32.3M	Sell	641,225 -59,550	-8%	-$3.12M	2.65%	12
2013 Q2	$34.4M	Buy	+700,775	New	+$38.1M	2.68%	14

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Edgar Lomax Company's LLY Position: Q4 2015 in Review

Edgar Lomax Company sold out of Eli Lilly (LLY) in Q4 2015, closing a stake of 112,285 shares — an estimated $9.4M sold.

Edgar Lomax Company first reported a position in LLY in Q2 2013 and held it in 10 quarters. The position peaked at $34.4M in Q2 2013. 1,220 funds tracked by Wall St. Rank hold LLY as of Q4 2015.

Edgar Lomax Company reported no remaining Eli Lilly position as of Q4 2015 after selling out during the quarter.
Edgar Lomax Company sold 112,285 Eli Lilly shares in Q4 2015, an estimated $9.4M.
Edgar Lomax Company first reported a position in Eli Lilly in Q2 2013 and held it in 10 quarters.
Edgar Lomax Company's Eli Lilly position peaked at $34.4M in Q2 2013.
1,220 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2015.

Based on Edgar Lomax Company's 13F filing for Q4 2015, filed 12 Feb 2016.